DUBAI, UNITED ARAB EMIRATES, 5 September 2024 — Pfizer announces the appointment of Elif Aral as Regional President for Middle East, Russia, and Africa (MERA) effective September 2024 to spearhead operations in the region and bring scientific breakthroughs in vaccines, oncology, rare diseases, internal medicine, hospitals, and inflammation and immunology.

In her new role, in addition to overseeing all therapeutic areas within the MERA region, Elif will drive strategic initiatives aimed at improving healthcare access and equity, working closely with regional partners and governments to ensure Pfizer’s leading portfolio and breakthroughs reach those who need them.

Continue reading Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa →

Sickle Cell Disease (SCD) is a significant public health concern in the GCC countries, with prevalence rates ranging from 0.24% to 5.8%

New hope for a once neglected disease: Pfizer highlights the essential approach to raise awareness about Sickle Cell Disease and reveals SHAPE survey key findings in Gulf

To further highlight its commitment on improving patient outcomes in the Gulf, Pfizer hosted a media roundtable to raise awareness on Sickle Cell Disease (SCD) and revealed key findings from Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey conducted in several countries including GCC. Attended by leading healthcare professionals, the roundtable was designed to share valuable insights on patient experiences, psychosocial burdens, and the impact of SCD on the quality of life of patients and caregivers.

Continue reading Pfizer highlights the essential approach to raise awareness about Sickle Cell Disease and reveals SHAPE survey key findings in Gulf →